ES2106573T3 - Composicion oftalmica que contiene un derivado de 1,5-benzoxatiepina para tratar glaucoma. - Google Patents

Composicion oftalmica que contiene un derivado de 1,5-benzoxatiepina para tratar glaucoma.

Info

Publication number
ES2106573T3
ES2106573T3 ES95100934T ES95100934T ES2106573T3 ES 2106573 T3 ES2106573 T3 ES 2106573T3 ES 95100934 T ES95100934 T ES 95100934T ES 95100934 T ES95100934 T ES 95100934T ES 2106573 T3 ES2106573 T3 ES 2106573T3
Authority
ES
Spain
Prior art keywords
optionally substituted
hydrogen
ophthalmic composition
benzoxatiepina
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95100934T
Other languages
English (en)
Spanish (es)
Inventor
Takahiro Ogawa
Takaaki Deguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2106573T3 publication Critical patent/ES2106573T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ES95100934T 1994-01-27 1995-01-25 Composicion oftalmica que contiene un derivado de 1,5-benzoxatiepina para tratar glaucoma. Expired - Lifetime ES2106573T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP747094 1994-01-27

Publications (1)

Publication Number Publication Date
ES2106573T3 true ES2106573T3 (es) 1997-11-01

Family

ID=11666688

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95100934T Expired - Lifetime ES2106573T3 (es) 1994-01-27 1995-01-25 Composicion oftalmica que contiene un derivado de 1,5-benzoxatiepina para tratar glaucoma.

Country Status (9)

Country Link
US (1) US5538974A (enExample)
EP (1) EP0667156B1 (enExample)
KR (1) KR950032169A (enExample)
CN (1) CN1116928A (enExample)
AT (1) ATE157870T1 (enExample)
CA (1) CA2141176A1 (enExample)
DE (1) DE69500660T2 (enExample)
ES (1) ES2106573T3 (enExample)
TW (1) TW316235B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
TR200100754T2 (tr) 1998-09-18 2001-10-22 Alcon Laboratories, Inc. Glausomanın tedavi edilmesi için serotonerjik 5HT2.
CA2397203A1 (en) * 2000-03-31 2001-10-11 Sandra C. Tobias Phosphoramidate prodrugs
FR2822467B1 (fr) * 2001-03-22 2003-12-12 Pf Medicament Derives benzoxathiepines et leur utilisation comme medicaments
JP2005511764A (ja) * 2001-12-14 2005-04-28 アルコン,インコーポレイテッド 緑内障の処置のためのアミノアルキルベンゾフラン−5−オール化合物
TW593302B (en) * 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
WO2004009586A1 (en) * 2002-07-19 2004-01-29 Biovitrum Ab Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
WO2004019874A2 (en) * 2002-08-30 2004-03-11 Alcon, Inc. Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
EP1581209A4 (en) * 2002-12-13 2009-03-11 Alcon Inc NEW BENZOPYRAN ANALOGUE AND ITS USE FOR THE TREATMENT OF GLAUKOM
TWI347847B (en) * 2003-08-20 2011-09-01 Santen Pharmaceutical Co Ltd Drug delivery system for sub-tenon administration of fine particles
WO2005053688A1 (en) * 2003-11-26 2005-06-16 Alcon, Inc. Substituted furo[2,3-g] indazoles for the treatment of glaucoma
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
WO2005058911A2 (en) * 2003-12-15 2005-06-30 Alcon, Inc. Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
US20050276867A1 (en) * 2004-06-09 2005-12-15 Allergan, Inc. Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative
US7425572B2 (en) * 2004-12-08 2008-09-16 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
TW200744567A (en) * 2005-09-23 2007-12-16 Alcon Inc Phenylethylamine analogs and their use for treating glaucoma
WO2007149728A2 (en) * 2006-06-20 2007-12-27 Alcon Research, Ltd. Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma
EA200900583A1 (ru) * 2006-10-20 2009-08-28 Общество С Ограниченной Ответственностью "Митотехнология" Композиция для регенерации, стимуляции роста и адаптации растений к различным стрессовым факторам
EA200900582A1 (ru) * 2006-10-20 2009-08-28 Общество С Ограниченной Ответственностью "Митотехнология" Фармацевтические композиции для профилактики и лечения глазных патологий
US8349902B2 (en) * 2007-01-29 2013-01-08 Mitotech Sa Pharmaceutical compositions useful for preventing and treating oncological diseases
US9427444B2 (en) * 2007-01-29 2016-08-30 Mitotech Sa Pharmaceutical and cosmetic compositions for accelerated healing of wounds and other surface damages
EA016723B1 (ru) * 2007-02-27 2012-07-30 Дели Инститьют Оф Фармасьютикал Сайнсиз Энд Рисерч (Дипсар) Синергетическая травяная композиция, применяемая при глаукоме, и способ ее получения
US9439916B2 (en) * 2007-04-11 2016-09-13 Mitotech Sa Composition for decelerating the aging in the organism and for extending the life time thereof and the use of said composition
US8518915B2 (en) 2007-06-29 2013-08-27 Mitotech Sa Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases
WO2010056145A1 (ru) 2008-11-12 2010-05-20 Общество С Ограниченной Ответственностью "Митотехнология" Способ умеренного повышения протонной проводимости биологических мембран при помощи митохондриально- адресованных делокализованных катионов
JP5659388B2 (ja) * 2009-06-10 2015-01-28 マイトテック ソシエテ アノニム 医学及び獣医眼科の使用のための医薬組成物
CN102791670A (zh) 2009-11-13 2012-11-21 米拓科技有限责任公司 基于定向于线粒体的抗氧化剂的药物物质
JP2013545800A (ja) 2010-12-20 2013-12-26 コルゲート・パーモリブ・カンパニー 親水性活性剤、疎水性構造化剤および油担体を含有するゼラチンカプセル化された口腔ケア組成物
CN103764132B (zh) 2011-06-03 2017-04-12 米托特克公司 线粒体靶向的抗氧化剂的口服制剂及其制备和用途
CN114767688A (zh) * 2019-09-04 2022-07-22 武汉科福新药有限责任公司 透皮促渗组合物及其在噻吗洛尔制剂中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK166779B1 (da) * 1983-12-14 1993-07-12 Takeda Chemical Industries Ltd 1,5-benzoxatiepinderivater eller farmaceutisk acceptable salte deraf, samt farmaceutisk praeparat indeholdende en saadan forbindelse
EP0229467A1 (en) * 1985-12-10 1987-07-22 Takeda Chemical Industries, Ltd. 1,5-Benzoxathiepin derivatives, their production and use

Also Published As

Publication number Publication date
EP0667156A1 (en) 1995-08-16
DE69500660T2 (de) 1998-02-26
CA2141176A1 (en) 1995-07-28
CN1116928A (zh) 1996-02-21
KR950032169A (ko) 1995-12-20
ATE157870T1 (de) 1997-09-15
TW316235B (enExample) 1997-09-21
DE69500660D1 (de) 1997-10-16
EP0667156B1 (en) 1997-09-10
US5538974A (en) 1996-07-23

Similar Documents

Publication Publication Date Title
ES2106573T3 (es) Composicion oftalmica que contiene un derivado de 1,5-benzoxatiepina para tratar glaucoma.
NO960380D0 (no) Middel til behandling av neurosykdommer
DE69716226D1 (de) Difluoroprostaglandin-Derivate und ihre Anwendung
DE19680619D2 (de) Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
IL98382A0 (en) Heterocyclene derivatives
DE3751006D1 (de) Psychostimulierendes mittel.
BR1100636A (pt) Agente terapêutico para o mal de parkinson, e, derivado da xantina
DE69326395D1 (de) Spirooxathiolan-quinuclidin-Derivat zur Behandlung des Sjögren-Syndroms
ATE284684T1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
ATE196080T1 (de) Verwendung von diphenylethanderivaten zur herstellung eines arzneimittels zur behandlung von glaukom
RU94045256A (ru) Применение бензо[g]хинолинов
DK0507318T3 (da) Benzothiazolderivater
DE69713648D1 (de) Benzopyranderivate und ihre Verwendung zur Behandlung von Herzkrankheiten
SE8802428D0 (sv) New compounds
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ATE122892T1 (de) Zusammensetzung gegen katarakt.
ATE157874T1 (de) Mittel zur verbesserung der peripheren durchblutung
ATE139764T1 (de) Substituierte benzoate-derivate
DE69327077D1 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
ATE120461T1 (de) Imidazolylpropylguanidinderivat, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel.
DE69424677D1 (de) Präparat zur behandlung der drogenabhängigkeit

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 667156

Country of ref document: ES